Uniphar Group PLC (UPR) - Total Liabilities

Latest as of June 2025: €1.19 Billion EUR ≈ $1.39 Billion USD

Based on the latest financial reports, Uniphar Group PLC (UPR) has total liabilities worth €1.19 Billion EUR (≈ $1.39 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Uniphar Group PLC (UPR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Uniphar Group PLC - Total Liabilities Trend (2016–2024)

This chart illustrates how Uniphar Group PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Uniphar Group PLC.

Uniphar Group PLC Competitors by Total Liabilities

The table below lists competitors of Uniphar Group PLC ranked by their total liabilities.

Company Country Total Liabilities
Shandong Intco Recycling Resources Co Ltd
SHG:688087
China CN¥4.58 Billion
LianChuang Electronic Technology Co Ltd
SHE:002036
China CN¥15.41 Billion
HMC Capital Ltd
AU:HMC
Australia AU$299.20 Million
Zhejiang Hangmin Co Ltd
SHG:600987
China CN¥3.81 Billion
Suven Life Sciences Limited
NSE:SUVEN
India Rs561.36 Million
CTT Correios de Portugal SA
LS:CTT
Portugal €5.53 Billion
Carlsberg Brewery Malaysia Bhd
KLSE:2836
Malaysia RM729.80 Million
Aksa Akrilik Kimya Sanayi AS
IS:AKSA
Turkey TL32.66 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Uniphar Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Uniphar Group PLC's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.76 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Uniphar Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Uniphar Group PLC (2016–2024)

The table below shows the annual total liabilities of Uniphar Group PLC from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 €1.01 Billion
≈ $1.19 Billion
+6.07%
2023-12-31 €955.94 Million
≈ $1.12 Billion
+16.43%
2022-12-31 €821.01 Million
≈ $959.85 Million
+18.40%
2021-12-31 €693.43 Million
≈ $810.69 Million
+8.70%
2020-12-31 €637.92 Million
≈ $745.80 Million
+10.04%
2019-12-31 €579.70 Million
≈ $677.73 Million
+14.57%
2018-12-31 €506.00 Million
≈ $591.57 Million
+68.52%
2017-12-31 €300.25 Million
≈ $351.03 Million
+0.82%
2016-12-31 €297.81 Million
≈ $348.18 Million
--

About Uniphar Group PLC

IR:UPR Ireland Medical Distribution
Market Cap
$1.22 Billion
€1.05 Billion EUR
Market Cap Rank
#9116 Global
#10 in Ireland
Share Price
€4.03
Change (1 day)
+0.75%
52-Week Range
€3.42 - €4.92
All Time High
€4.96
About

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more